Inhibitory effects of anthocyanins on secretion of Helicobacter pylori CagA and VacA toxins

Sa-Hyun Kim1, Min Park, Hyunjun Woo

  • 1Department of Biomedical Laboratory Science, College of Health Science, Yonsei University, Wonju, Republic of Korea.

Insights

Cyanidin 3-O-glucoside (C3G), a plant pigment, was found to inhibit the secretion of key toxins from Helicobacter pylori. This anthocyanin targets the SecA protein, offering a novel approach to combatting H. pylori infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Natural Products Chemistry

Background:

  • Helicobacter pylori is a significant human pathogen associated with various gastrointestinal diseases.
  • Anthocyanins are plant-derived compounds with potential therapeutic properties, including antimicrobial activity.
  • Key virulence factors of H. pylori include cytotoxin-associated protein A (CagA) and vacuolating cytotoxin A (VacA), which contribute to pathogenesis.

Purpose of the Study:

  • To investigate the in vitro effects of specific anthocyanins on the expression and secretion of H. pylori toxins CagA and VacA.
  • To elucidate the molecular mechanism by which anthocyanins might inhibit H. pylori virulence factor secretion.

Main Methods:

  • Utilized H. pylori reference strain 60190 (CagA(+)/VacA(+)).
  • Treated bacterial cultures with four anthocyanins: cyanidin 3-O-glucoside (C3G), peonidin 3-O-glucoside (Peo3G), pelargonidin 3-O-glucoside (Pel3G), and malvidin 3-O-glucoside (M3G).
  • Employed Western blotting to detect and quantify the secretion of CagA and VacA; analyzed gene transcription using RT-PCR.

Main Results:

  • Cyanidin 3-O-glucoside (C3G) significantly inhibited the secretion of both CagA and VacA, leading to their intracellular accumulation.
  • C3G did not affect the expression of cagA and vacA genes but suppressed the transcription of secA.
  • SecA, a protein translocation component, was identified as a potential target of C3G's inhibitory action on toxin secretion.

Conclusions:

  • Cyanidin 3-O-glucoside demonstrates potential as an agent to disrupt H. pylori virulence.
  • The inhibition of CagA and VacA secretion by C3G appears to be mediated through the suppression of secA transcription.
  • This study provides the first evidence for C3G's mechanism in inhibiting H. pylori toxin secretion via SecA pathway modulation.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.